These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 38838390

  • 1. An induced mutation of ABC-transporter component VraF(K84E) contributes to vancomycin resistance and virulence in Staphylococcus aureus strain MW2.
    Cao R, Su H, Wei Z, He Z, Pan T, Li Y, Sun B.
    Int J Med Microbiol; 2024 Jun; 315():151624. PubMed ID: 38838390
    [Abstract] [Full Text] [Related]

  • 2. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
    Meehl M, Herbert S, Götz F, Cheung A.
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2679-89. PubMed ID: 17502406
    [Abstract] [Full Text] [Related]

  • 3. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.
    Cafiso V, Bertuccio T, Spina D, Purrello S, Campanile F, Di Pietro C, Purrello M, Stefani S.
    PLoS One; 2012 Aug; 7(1):e29573. PubMed ID: 22253738
    [Abstract] [Full Text] [Related]

  • 4. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM, Slavetinsky CJ, Kuhn S, Hauser JN, Nega M, Mishra NN, Gekeler C, Bayer AS, Peschel A.
    mBio; 2018 Dec 18; 9(6):. PubMed ID: 30563904
    [Abstract] [Full Text] [Related]

  • 5. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
    Howden BP, McEvoy CR, Allen DL, Chua K, Gao W, Harrison PF, Bell J, Coombs G, Bennett-Wood V, Porter JL, Robins-Browne R, Davies JK, Seemann T, Stinear TP.
    PLoS Pathog; 2011 Nov 18; 7(11):e1002359. PubMed ID: 22102812
    [Abstract] [Full Text] [Related]

  • 6. Role of the msaABCR Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus.
    G C B, Sahukhal GS, Elasri MO.
    Antimicrob Agents Chemother; 2019 Oct 18; 63(10):. PubMed ID: 31307991
    [Abstract] [Full Text] [Related]

  • 7. Repeated Exposure of Vancomycin to Vancomycin-Susceptible Staphylococcus aureus (VSSA) Parent Emerged VISA and VRSA Strains with Enhanced Virulence Potentials.
    Nguyen A, Roy JJS, Kim JH, Yun KH, Lee W, Kim KK, Kim T, Chaurasia AK.
    J Microbiol; 2024 Jul 18; 62(7):535-553. PubMed ID: 38814539
    [Abstract] [Full Text] [Related]

  • 8. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K, Aiba Y, Tan XE, Watanabe S, Kiga K, Sato'o Y, Boonsiri T, Li FY, Sasahara T, Taki Y, Azam AH, Zhang Y, Cui L.
    Sci Rep; 2020 Sep 30; 10(1):16107. PubMed ID: 32999359
    [Abstract] [Full Text] [Related]

  • 9. A Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal Peptidase.
    Morisaki JH, Smith PA, Date SV, Kajihara KK, Truong CL, Modrusan Z, Yan D, Kang J, Xu M, Shah IM, Mintzer R, Kofoed EM, Cheung TK, Arnott D, Koehler MF, Heise CE, Brown EJ, Tan MW, Hazenbos WL.
    mBio; 2016 Sep 06; 7(5):. PubMed ID: 27601569
    [Abstract] [Full Text] [Related]

  • 10. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
    Hort M, Bertsche U, Nozinovic S, Dietrich A, Schrötter AS, Mildenberger L, Axtmann K, Berscheid A, Bierbaum G.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0052821. PubMed ID: 34668723
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM, Mishra NN, Park KT, Lee GY, Park YH, Bayer AS, Yang SJ.
    J Microbiol; 2017 Feb 31; 55(2):153-159. PubMed ID: 28120188
    [Abstract] [Full Text] [Related]

  • 12. VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.
    Dai Y, Chang W, Zhao C, Peng J, Xu L, Lu H, Zhou S, Ma X.
    Antimicrob Agents Chemother; 2017 May 31; 61(5):. PubMed ID: 28289032
    [Abstract] [Full Text] [Related]

  • 13. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
    Camargo IL, Neoh HM, Cui L, Hiramatsu K.
    Antimicrob Agents Chemother; 2008 Dec 31; 52(12):4289-99. PubMed ID: 18824611
    [Abstract] [Full Text] [Related]

  • 14. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
    Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K.
    Antimicrob Agents Chemother; 2010 Dec 31; 54(12):5222-33. PubMed ID: 20837752
    [Abstract] [Full Text] [Related]

  • 15. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.
    Gardete S, Kim C, Hartmann BM, Mwangi M, Roux CM, Dunman PM, Chambers HF, Tomasz A.
    PLoS Pathog; 2012 Feb 31; 8(2):e1002505. PubMed ID: 22319446
    [Abstract] [Full Text] [Related]

  • 16. A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus.
    Rao Y, Peng H, Shang W, Hu Z, Yang Y, Tan L, Li M, Zhou R, Rao X.
    J Adv Res; 2022 Sep 31; 40():167-178. PubMed ID: 36100324
    [Abstract] [Full Text] [Related]

  • 17. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
    Pillai SK, Gold HS, Sakoulas G, Wennersten C, Moellering RC, Eliopoulos GM.
    Antimicrob Agents Chemother; 2007 Jun 31; 51(6):2223-5. PubMed ID: 17404001
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of Staphylococcus aureus towards Polymyxins.
    Vestergaard M, Nøhr-Meldgaard K, Bojer MS, Krogsgård Nielsen C, Meyer RL, Slavetinsky C, Peschel A, Ingmer H.
    mBio; 2017 Sep 05; 8(5):. PubMed ID: 28874470
    [Abstract] [Full Text] [Related]

  • 19. Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure.
    Haaber J, Friberg C, McCreary M, Lin R, Cohen SN, Ingmer H.
    mBio; 2015 Jan 13; 6(1):. PubMed ID: 25587013
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of vancomycin resistance in Staphylococcus aureus.
    Gardete S, Tomasz A.
    J Clin Invest; 2014 Jul 13; 124(7):2836-40. PubMed ID: 24983424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.